Metra Biosystems Inc regulatory update

MTRA's Pyrilinks-D urinary assay received 510(k) clearance from the FDA to measure the excretion of deoxypyridinoline (Dpd) crosslinks as an indicator of bone resorption. MTRA will immediately begin marketing the test for clinical diagnostic use. The price to patients will range from $30 to $80. ...